CLASS II ONGOING Device recall · Reported 31 May 2023 · FDA Enforcement Report

IVX Station-For use in the automated preparation recalled by OmniCell

OmniCell is recalling Omnicell IVX Station-For use in the automated preparation of pharmaceutical admixtures, distributed in Alabama, New York. The recall was initiated on 27 Mar 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 00860006285005 Serial Numbers: IVXS000014, IVXS000015, IVXS000016, IVXS000017, IVXS000018. IVXS000019
Quantity recalled6 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1617-2023
FDA event ID
92136
Recalling firm
OmniCell, Warrendale, PA
Classification
Class II
Status
Ongoing
Recall initiated
27 Mar 2023
FDA classified
22 May 2023
Reported
31 May 2023
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Device Malfunction

Timeline

27 Mar 2023Recall initiated by company
22 May 2023Classified by FDA+56 days
31 May 2023Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

IVX Station does not account for inherent scale inaccuracy or variability, could result in a preparation being passed that is outside of the dose accuracy stated in the product labeling

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Omnicell IVX Station-For use in the automated preparation of pharmaceutical admixtures and syringes Model Number: 298921373

Where it was distributed

AL, NY

AlabamaNew York

Questions about this recall

Is IVX Station-For use in the automated preparation of pharmaceutical admixtures and syringes recalled?

Yes. OmniCell recalled IVX Station-For use in the automated preparation of pharmaceutical admixtures and syringes on 27 Mar 2023. The recall is Class II and its status is Ongoing. Recall number Z-1617-2023.

Why was it recalled?

IVX Station does not account for inherent scale inaccuracy or variability, could result in a preparation being passed that is outside of the dose accuracy stated in the product labeling

Which lots are affected?

UDI-DI: 00860006285005 Serial Numbers: IVXS000014, IVXS000015, IVXS000016, IVXS000017, IVXS000018. IVXS000019

Where was it sold?

AL, NY

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from OmniCell

All 3

Other Syringes & Needles recalls

All 1,060